Parker Waichman LLP

Avandia Decision Coming in September

Avandia Decision Coming in September. European regulators will decide by September if Avandia will be allowed to stay on the market there. The European Medicines Agency (EMEA) said yesterday that it is still reviewing GlaxoSmithKline’s controversial diabetes drug, which has been linked to an increased risk of heart attacks. Since 2000, the EMEA has contra-indicated […]

Avandia Risk

Avandia Decision Coming in September. European regulators will decide by September if Avandia will be allowed to stay on the market there. The European Medicines Agency (EMEA) said yesterday that it is still reviewing GlaxoSmithKline’s controversial diabetes drug, which has been linked to an increased risk of heart attacks.

Since 2000, the EMEA has contra-indicated Avandia for anyone with heart failure or a history of heart failure. Since then, use of Avandia, as well as Avandame (Avandia in combination with metformin) and Avaglim (Avandia in combination with glimepiride), has been further restricted several times by the EMA by new warnings and contra-indications on their use in patients with heart problems.

The EMEA initiated a new review of Avandia earlier this month on the request of the European Commission following publication of studies questioning the cardiovascular safety of the medicine.

In the US, a Food & Drug Administration (FDA) advisory panel took up Avandia last week. Since 2007, Avandia has borne a black box label – the FDA’s most urgent safety warning – regarding its heart attack risks. An FDA advisory panel met last week to consider further restrictions on the controversial diabetes drug.

12 of the panel’s 33 members voted that Avandia should be withdrawn

According to an earlier report in The New York Times, 12 of the panel’s 33 members voted that Avandia should be withdrawn; 10 voted that its sales should be restricted and the warnings on its label enhanced; 7 voted only to support enhanced warnings on the drug’s label; and 3 voted that the drug should continue to be sold with its present warnings unchanged.

The FDA is not required to follow the recommendations of such panels, but does so in most cases. However, the lack of unity among panel members in the case of Avandia makes it hard to predict what the agency will do, The Times said.

Yesterday, we reported that the FDA had ordered GlaxoSmithKline to halt enrollment in a study called TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation) over safety concerns. TIDE was designed to compare the long-term effects of Avandia with another diabetes drug called Actos.

Actos has not raised as many safety concerns as Avandia. For some time now, scientists inside and outside the FDA have opposed TIDE, saying it is unethical to compare Avandia, with its known cardiac risks, with a seemingly safer alternative.

According to The Boston Globe, the FDA said it halted recruitment in TIDE because it needs time to study new evidence of the Avandia’s risks.

The agency is demanding that Glaxo update physicians and ethics oversight boards involved in the trial regarding all new safety information about the drug. The agency did not say how long the enrollment halt would last.

Need Legal Help Regarding Avandia Risk?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Great place. Good service and helped with everything needed.
Bus Ministry
6 years ago
5 Star Reviews 150
I must have called my attorney Alex Tovstolug and his paralegal Katherine Snedecor over 70 times since my case arrived in Parker Waichman's litigation dept. Honestly, I don't remember one time where my call wasn't taken or returned the same day. With every encounter, the staff and attorneys at Parker Waichman treated me with respect, understanding and, above all, patience. Alex and Katherine always made me feel as if my case was their top priority, and that they were only concerned with getting the best outcome FOR ME. In the end, we did get the best outcome and I was privileged to see Alex at trial and at his finest! I can't thank you guys enough for taking my case, for working so hard on my case; and for always putting me first.
Sonia Demitre
5 years ago
5 Star Reviews 150
They are very fast in their work recommended
Katty Chamorro
4 months ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
  • (973) 323-3603
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
  • (239) 390-1000
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
  • (718) 469-6900
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
  • (631) 390-0800
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
  • (212) 267-6700
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
  • (800) 968-7529
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
  • (718) 469-6900
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
  • (516) 466-6500